Screening of GPCR drugs for repurposing in breast cancer

• मुख्य लेखकों: Noor Mazin Abdulkareem (लेखक), Raksha Bhat (लेखक), Reid T. Powell (लेखक), Soumya Chikermane (लेखक), Soham Yande (लेखक), Lisa Trinh (लेखक), Hala Y. Abdelnasser (लेखक), Mantasha Tabassum (लेखक), Alexis Ruiz (लेखक), Mary Sobieski (लेखक), Nghi D. Nguyen (लेखक), Jun Hyoung Park (लेखक), Camille A. Johnson (लेखक), Benny A. Kaipparettu (लेखक), Richard A. Bond (लेखक), Michael Johnson (लेखक), Clifford Stephan (लेखक), Meghana V. Trivedi (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Drug repurposing can overcome both substantial costs and the lengthy process of new drug discovery and development in cancer treatment. Some Food and Drug Administration (FDA)-approved drugs have been found to have the potential to be repurposed as anti-cancer drugs. However, the progress is slow du...